Quest Diagnostics Inc. Stock Climbs 3.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Quest Diagnostics Inc. rallied 3.9% to $247.08 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.4% to 7,585.73 and Dow Jones Industrial Average falling 0.6% to 52,093.11.

This was the stock's third consecutive day of gains.

Quest Diagnostics Inc. closed 0.0% below its 52-week high of $247.19, which the company achieved on August 27th.

The stock outperformed some of its peers, as UnitedHealth Group Inc. fell 2.0% to $375.93, IQVIA Holdings Inc. rose 1.5% to $269.67, and Centene Corp. fell 2.52% to $67.66.

Trading volume totaled 1.4 million, compared to the 50-day average of 956,586.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 15, 2026 16:35 ET (20:35 GMT)